Popular Articles

Finance Committee Senators: Reform Bill Trimmed To Less Than $1 Trillion
Some senators on the Finance Committee said Thursday they"ve moved closer to cutting their health reform bill"s cost to under $1 trillion.
generic viagra online
Prominent Bioinformatics Expert To Join Harvard School Of Public Health Faculty And Become Chair Of Dana-Farber Department Of Biostatistics
Giovanni Parmigiani, PhD, a noted leader in applying bioinformatics tools to cancer studies and medical decision-making, has been appointed professor of biostatistics at Harvard School of Public Health (HSPH) and as chair of the Department of Biostatistics and Computational Biology at Dana-Farber Cancer Institute.
News of the day
World Premiere Of Innovative Medical Devices For Neurosurgery
Renishaw, a world leader in engineering technologies, is introducing an exciting range of high precision systems for functional and stereotactic neurosurgery at the 15th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery (WSSFN) taking place in Toronto, Canada, from May 24th to 27th 2009. These include the neuromate® surgical robot, and image-guided stereotactic technologies, some of which are still in development.
Medical Devices

GE, Big Vendors Corner EMR Market; Smaller Vendors Explore Health 2.0

Staying ahead of the upcoming drive to sell electronic health records to hospitals and physicians may be difficult for smaller vendors, Pharmawire/Financial Times reports. General Electric announced a program last week to provide health care organizations with financing options to purchase health technology through its financial services arm even as it sells electronic records through its health care wing. Other large vendors like Cerner and McKesson will be able to keep up, but smaller producers will be left behind, industry experts said. A rush of new customers is expected in upcoming years because the American Recovery and Reinvestment Act provides incentives - more than $20 billion - for health providers to purchase the technology (Avallone and Longpre, 6/24). In other news, Atlas Venture, a venture capital firm, is gearing up to make investments that will "improve health care by empowering patients," the Wall Street Journal"s blog, Venture Capital Dispatch, reports. The company has recently invested in Keas, a health 2.0 company that develops Web technologies that help consumers "better their health." Atlas partner and technology specialist Jeff Fagnan said "the firm may make four or five of these types of investments with its current fund... which closed at $283 million last year" (Gormley, 6/25). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):